{"id":13082,"date":"2022-01-11T21:01:56","date_gmt":"2022-01-11T20:01:56","guid":{"rendered":"https:\/\/lombardialifesciences.it\/mission-cancer-nuovi-bandi-per-combattere-il-cancro-in-europa\/"},"modified":"2023-10-17T09:37:42","modified_gmt":"2023-10-17T07:37:42","slug":"mission-cancer-nuovi-bandi-per-combattere-il-cancro-in-europa","status":"publish","type":"post","link":"https:\/\/lombardialifesciences.it\/en\/mission-cancer-nuovi-bandi-per-combattere-il-cancro-in-europa\/","title":{"rendered":"Mission Cancer: nuovi bandi per combattere il cancro in Europa"},"content":{"rendered":"<p>A dicembre la Commissione ha adottato un emendamento al programma di lavoro Horizon Europe per il 2021-2022, aumentando il budget totale a 15,4 miliardi di euro: si tratta di un aumento di 723 milioni di euro che include 673,24 milioni di euro dedicati alle Mission UE.<br \/>\nNello specifico la missione sul cancro investir\u00e0 125,65 milioni di euro per sviluppare nuovi metodi e tecnologie nello screening del cancro e nella diagnosi precoce, stabilire misure per la qualit\u00e0 della vita, nonch\u00e9 comprendere l&#8217;impatto dei fattori di rischio e dei determinanti della salute sullo sviluppo e sulla progressione del cancro.<\/p>\n<p>Di seguito il dettaglio dei nuovi bandi aperti il 22 dicembre:<\/p>\n<ul style=\"list-style-type: square;\">\n<li><a href=\"https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/topic-details\/horizon-miss-2021-cancer-02-01;callCode=HORIZON-MISS-2021-CANCER-02;freeTextSearchKeyword=;matchWholeText=true;typeCodes=1;statusCodes=31094501,31094502,31094503;programmePeriod=null;programCcm2Id=null;programDivisionCode=null;focusAreaCode=null;destination=null;mission=null;geographicalZonesCode=null;programmeDivisionProspect=null;startDateLte=null;startDateGte=null;crossCuttingPriorityCode=null;cpvCode=null;performanceOfDelivery=null;sortQuery=sortStatus;orderBy=asc;onlyTenders=false;topicListKey=callTopicSearchTableState\">HORIZON-MISS-2021-CANCER-02-01<\/a>: Develop new methods and technologies for cancer screening and early detection<\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/topic-details\/horizon-miss-2021-cancer-02-02;callCode=HORIZON-MISS-2021-CANCER-02;freeTextSearchKeyword=;matchWholeText=true;typeCodes=1;statusCodes=31094501,31094502,31094503;programmePeriod=null;programCcm2Id=null;programDivisionCode=null;focusAreaCode=null;destination=null;mission=null;geographicalZonesCode=null;programmeDivisionProspect=null;startDateLte=null;startDateGte=null;crossCuttingPriorityCode=null;cpvCode=null;performanceOfDelivery=null;sortQuery=sortStatus;orderBy=asc;onlyTenders=false;topicListKey=callTopicSearchTableState\">HORIZON-MISS-2021-CANCER-02-02<\/a>: Develop and validate a set of quality of life and patient preference measures for cancer patients and survivors<\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/topic-details\/horizon-miss-2021-cancer-02-03;callCode=HORIZON-MISS-2021-CANCER-02;freeTextSearchKeyword=;matchWholeText=true;typeCodes=1;statusCodes=31094501,31094502,31094503;programmePeriod=null;programCcm2Id=null;programDivisionCode=null;focusAreaCode=null;destination=null;mission=null;geographicalZonesCode=null;programmeDivisionProspect=null;startDateLte=null;startDateGte=null;crossCuttingPriorityCode=null;cpvCode=null;performanceOfDelivery=null;sortQuery=sortStatus;orderBy=asc;onlyTenders=false;topicListKey=callTopicSearchTableState\">HORIZON-MISS-2021-CANCER-02-03<\/a>: Better understanding of the impact of risk factors and health determinants on the development and progression of cancer<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>A dicembre la Commissione ha adottato un emendamento al programma di lavoro Horizon Europe per il 20&#8230;<\/p>\n","protected":false},"author":1,"featured_media":13077,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[44],"tags":[130,235],"class_list":["post-13082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-horizon-europe","tag-mission-on-cancer"],"acf":[],"_links":{"self":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/13082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/comments?post=13082"}],"version-history":[{"count":1,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/13082\/revisions"}],"predecessor-version":[{"id":17701,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/13082\/revisions\/17701"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media\/13077"}],"wp:attachment":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media?parent=13082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/categories?post=13082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/tags?post=13082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}